Khoubian Jake F, Kikkawa Don O, Gonnering Russell S
Division of Ophthalmic Facial Plastic and Reconstructive Surgery, UCSD Department of Ophthalmology, La Jolla, California 92037, USA.
Ophthalmic Plast Reconstr Surg. 2006 Jul-Aug;22(4):248-52. doi: 10.1097/01.iop.0000226863.21961.35.
To investigate the efficacy of canalicular trephination and silicone stent intubation procedure for relief of epiphora according to the level of obstruction within the canaliculus.
The medical records of 32 patients (41 eyes) who underwent canalicular trephination followed by silicone stent intubation of the nasolacrimal system for the treatment of canalicular obstruction were retrospectively reviewed. Canalicular obstruction was diagnosed on preoperative irrigation and probing. Level of obstruction was confirmed by intraoperative probing. Proximal obstruction was classified as those within 4 mm of the punctum, distal obstruction as those 5 mm or greater from the punctum, and common canalicular obstruction as those 10 mm or greater from the punctum. Silicone stents were kept in for a minimum of 5 months, and outcome was based on symptomatic relief of epiphora at the end of follow-up (minimum of 6 months). Partial relief of epiphora was defined as improved symptoms and at least a fair clearance on fluorescein dye disappearance testing.
On average, 49% of eyes had complete relief of epiphora, 38% had partial relief, and 13% had no relief. Eighty percent of eyes with distal lower canalicular obstructions had complete relief of epiphora and 20% had partial relief of epiphora. Eyes with distal bicanalicular obstructions had 66% complete and 33% partial relief. Patients with common canalicular obstructions had 59% complete, 29% partial, and 12% no relief. Proximal bicanalicular obstructions were the least successful, with 55% partial relief and 45% no relief.
Success of canalicular trephination and silicone stent intubation for treatment of canalicular obstruction is based on the site of obstruction. Distal monocanalicular obstructions have the highest degree of symptomatic epiphora relief, followed by distal bicanalicular, common, and proximal obstructions.
根据泪小管内阻塞的程度,探讨泪小管造孔及硅胶支架植入术治疗溢泪的疗效。
回顾性分析32例(41只眼)因泪小管阻塞接受泪小管造孔及鼻泪系统硅胶支架植入术患者的病历资料。术前通过冲洗和探通诊断泪小管阻塞。术中探通确定阻塞程度。近端阻塞定义为距离泪点4mm以内的阻塞,远端阻塞为距离泪点5mm或更远的阻塞,共同泪小管阻塞为距离泪点10mm或更远的阻塞。硅胶支架至少留置5个月,结局基于随访结束时(至少6个月)溢泪症状的缓解情况。溢泪部分缓解定义为症状改善且荧光素染料消失试验至少有较好的清除效果。
平均而言,49%的眼溢泪完全缓解,38%部分缓解,13%未缓解。远端下泪小管阻塞的眼中80%溢泪完全缓解,20%部分缓解。远端双泪小管阻塞的眼66%完全缓解,33%部分缓解。共同泪小管阻塞的患者59%完全缓解,29%部分缓解,12%未缓解。近端双泪小管阻塞最不成功,55%部分缓解,45%未缓解。
泪小管造孔及硅胶支架植入术治疗泪小管阻塞的成功率取决于阻塞部位。远端单泪小管阻塞溢泪症状缓解程度最高,其次是远端双泪小管阻塞、共同泪小管阻塞和近端阻塞。